Total Payments
$83,879
2024 Payments
$1,101
Companies
42
Transactions
712
Medicare Patients
5,122
Medicare Billing
$534,588
Payment Breakdown by Category
Other$64,025 (76.3%)
Food & Beverage$12,177 (14.5%)
Travel$7,666 (9.1%)
Education$10.94 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $64,025 | 41 | 76.3% |
| Food and Beverage | $12,177 | 637 | 14.5% |
| Travel and Lodging | $7,666 | 32 | 9.1% |
| Education | $10.94 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $72,944 | 126 | $0 (2020) |
| ABBVIE INC. | $1,831 | 122 | $0 (2024) |
| Covidien LP | $1,054 | 13 | $0 (2020) |
| Janssen Biotech, Inc. | $1,026 | 74 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $1,016 | 54 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $875.77 | 74 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $793.02 | 53 | $0 (2024) |
| Daiichi Sankyo Inc. | $415.90 | 21 | $0 (2024) |
| Celgene Corporation | $403.02 | 27 | $0 (2024) |
| PFIZER INC. | $356.87 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,101 | 61 | ABBVIE INC. ($396.12) |
| 2023 | $1,098 | 71 | AbbVie Inc. ($265.85) |
| 2022 | $1,637 | 117 | ABBVIE INC. ($469.89) |
| 2021 | $1,548 | 92 | AbbVie Inc. ($299.74) |
| 2020 | $1,198 | 68 | IRONWOOD PHARMACEUTICALS, INC ($212.61) |
| 2019 | $17,494 | 102 | Allergan Inc. ($15,746) |
| 2018 | $39,053 | 124 | Allergan Inc. ($37,592) |
| 2017 | $20,750 | 77 | Allergan Inc. ($19,564) |
All Payment Transactions
712 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | ABBVIE INC. | CREON (Drug), LINZESS, VIBERZI | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Oncology | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $18.61 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Gastroenterology | ||||||
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | CREON (Drug), LINZESS, VIBERZI | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: VIROLOGY | ||||||
| 10/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.56 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $20.39 | General |
| Category: GI | ||||||
| 09/25/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $29.51 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 09/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: Immunology | ||||||
| 09/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.86 | General |
| Category: Neuroscience | ||||||
| 08/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,194 | 1,325 | $444,561 | $130,070 |
| 2022 | 23 | 1,199 | 1,323 | $500,896 | $138,130 |
| 2021 | 27 | 1,076 | 1,196 | $485,656 | $123,544 |
| 2020 | 40 | 1,653 | 2,052 | $560,620 | $142,844 |
Total Patients
5,122
Total Services
5,896
Medicare Billing
$534,588
Procedure Codes
111
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 282 | 367 | $51,380 | $31,798 | 61.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 102 | 104 | $84,760 | $19,650 | 23.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 168 | 168 | $31,494 | $18,986 | 60.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 151 | 153 | $68,850 | $6,763 | 9.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 44 | 52 | $10,140 | $6,669 | 65.8% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 40 | 41 | $33,161 | $6,441 | 19.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 40 | 40 | $9,494 | $6,026 | 63.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 58 | 58 | $39,730 | $4,306 | 10.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 66 | $6,600 | $3,726 | 56.5% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $21,137 | $3,576 | 16.9% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 30 | 30 | $14,850 | $3,125 | 21.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 33 | 34 | $5,270 | $3,072 | 58.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 36 | 49 | $4,165 | $2,775 | 66.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 38 | 38 | $4,649 | $2,550 | 54.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 14 | 14 | $8,120 | $2,376 | 29.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 13 | 25 | $5,250 | $2,199 | 41.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 11 | 11 | $6,380 | $1,737 | 27.2% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 13 | 13 | $7,410 | $1,484 | 20.0% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 12 | 13 | $18,042 | $1,345 | 7.5% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 12 | 12 | $12,200 | $1,172 | 9.6% |
| 74328 | Review by radiologist of image from tube placement into bile duct using an endoscope | Facility | 2023 | 13 | 17 | $1,479 | $294.44 | 19.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 218 | 287 | $40,180 | $25,493 | 63.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 93 | 93 | $76,200 | $17,721 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 152 | 152 | $28,468 | $17,706 | 62.2% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 45 | 46 | $49,670 | $8,516 | 17.1% |
About Dr. Michael Sanders, MD
Dr. Michael Sanders, MD is a Gastroenterology healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275554636.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Sanders, MD has received a total of $83,879 in payments from pharmaceutical and medical device companies, with $1,101 received in 2024. These payments were reported across 712 transactions from 42 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($64,025).
As a Medicare-enrolled provider, Sanders has provided services to 5,122 Medicare beneficiaries, totaling 5,896 services with total Medicare billing of $534,588. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Mobile, AL
- Active Since 07/21/2006
- Last Updated 10/13/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1275554636
Products in Payments
- LINZESS (Drug) $72,667
- STELARA (Biological) $1,210
- Linzess (Drug) $851.32
- VIBERZI (Drug) $595.58
- TRULANCE (Drug) $586.35
- RINVOQ (Biological) $539.27
- HUMIRA (Biological) $478.37
- Beacon (Device) $434.05
- ZEPOSIA (Drug) $390.53
- INJECTAFER (Drug) $388.23
- Barrx (Device) $373.96
- XELJANZ (Drug) $310.10
- ESOPHYX (Device) $265.24
- SKYRIZI (Biological) $236.17
- Trulance (Drug) $221.22
- ENTYVIO (Biological) $218.83
- XIFAXAN (Drug) $215.99
- IBSRELA (Drug) $178.87
- EchoTip (Device) $174.82
- ZENPEP (Drug) $140.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Mobile
Jack Dipalma, Md, MD
Gastroenterology — Payments: $982,519
Gastroenterology $982,519
Jorge Herrera, Md, MD
Gastroenterology — Payments: $326,803
Gastroenterology $326,803
Dr. Matthew Eves, M.d, M.D
Gastroenterology — Payments: $73,009
Gastroenterology $73,009
Dr. Susan Fleet, Md, MD
Gastroenterology — Payments: $15,558
Gastroenterology $15,558
Dr. Cody Barnett
Gastroenterology — Payments: $10,790
Gastroenterology $10,790
Reynaldo Rodriguez, Do, DO
Gastroenterology — Payments: $8,450
Gastroenterology $8,450